Xofigo Injection
Product Images NDC 50419-208

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Xofigo (NDC 50419-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

This is a chart/table showing the probability of survival for patients under treatment with Xofigo versus placebo over a period of 33 months. The number of patients at risk is listed for each time point.*

FDA Label Image

Vial Label Nist (Image 02)

This is a description of a medication with the NDC code 50419-208-01. The medication is a single-dose vial containing 6mL of sterile solution of radium Ra 223 dichloride injection manufactured for use in intravenous administration. The vial is intended for one-time use only, and any unused portion should be discarded. The solution has a strength of 1100 kBq/mL (30 microcurie/mL) and is produced by the CES facility located in Whippany, NJ 07981. Additionally, it has a strength of 6600 kBg/vial (178 microcurie/vial) at 5 AM (ST (12 noon CET) on reference date. The specific lot number for this medication is BXp: 85518682.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.